Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
ElsMed
Samsung

MR Linac Research Consortium to Develop MRI-Guided Radiotherapy for Cancer Treatment

By Medimaging International staff writers
Posted on 16 Jun 2014
High-powered institutions to join consortium to advance MRI-guided radiptherapy. Elekta (Stockholm, Sweden) and Philips Healthcare (Best, The Netherlands) reported that The Institute of Cancer Research (ICR), London, UK), a world-leading cancer research institution, working with its clinical partner the Royal Marsden NHS [National Health Service] Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with an objective to develop an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Combining a sophisticated digital linac with an MRI system would greatly enhance real-time visualization of cancer targets during the delivery of therapeutic radiation.

“The addition of The Institute of Cancer Research [ICR] to the consortium further strengthens this growing partnership of clinical centers,” said Niklas Savander, Elekta president and CEO. “The ICR is a prominent cancer research institute and has contributed significantly in this arena for over a century. Its unique partnership with The Royal Marsden and ‘bench-to-bedside’ approach allows the ICR to deliver exceptional results. All of these factors make the ICR and The Royal Marsden a perfect fit as we advance MRI-guided radiotherapy.”

“The development of MRI-guided radiation therapy establishes a new vision for clinical radiation oncology for the treatment of cancer,” said Prof. Uwe Oelfke, MCCPM, FInstP, and head of the joint department of physics at The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust. “The translation of this novel technical approach into clinical practice faces a number of challenges ideally addressed by a group of world leading radiotherapy centers, each contributing with its specific expertise. Being a member of the consortium is a prerequisite to shape this exciting future of radiation therapy. Our current Cancer Research UK-funded research program on adaptive and image-guided therapy, together with the activities on MRI within our Cancer Research UK imaging center, are an excellent research environment to make leading contributions to the joint efforts of the consortium. The ICR's initial research focus for MRI-guided radiation therapy will be on pelvic malignancies, where the excellent soft tissue contrast of MR images directly before or during treatment will substantially enhance treatment options and quality.”

The ICR is the sixth member to join the research consortium that assesses the novel technology, which brings together state-of-the-art radiation therapy and MRI in a single system. The consortium also includes the University Medical Center Utrecht (Utrecht, the Netherlands), The University of Texas MD Anderson Cancer Center (Houston, TX, USA), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands), Sunnybrook Health Sciences Center (Toronto, Ontario, Canada) and The Froedtert & Medical College of Wisconsin Cancer Center (Milwaukee, WI, USA).

“MRI-guided radiation therapy has the promise to become a highly targeted treatment for cancer,” said Gene Saragnese, CEO imaging systems at Philips Healthcare. “The realization of this promise requires the collaboration between leaders in interventional imaging and radiation therapy delivery, as well as clinical innovators in oncology. We are convinced that the deep clinical knowledge and expertise of the Institute of Cancer Research will be a strong asset to the growing research consortium.”

The research consortium, since its launch in 2012, has taken several steps toward its goal. On April 5, 2014, the University Medical Center Utrecht began installing the first generation MRI-guided radiation therapy system for nonclinical testing, which includes the performance evaluation of MRI pulse sequences, evaluation of different adaptive delivery approaches, establishing quality assurance techniques and defining workflow. Several of the sites are now undertaking treatment planning evaluation using the Monte Carlo based MRI-corrected algorithms in a research version of Elekta’s Monaco treatment planning system. Furthermore, a number of the consortium centers have active research programs linked to the MRI-guided radiation therapy system and have submitted abstracts to the American Association of Physicists in Medicine (AAPM) annual meeting (July 20–24, 2014, Austin, TX, USA), where some specific sessions will be covering the latest advances in MRI-guided radiotherapy.

Related Links:

Elekta 
Philips Healthcare 
Institute of Cancer Research, London



PHS Technologies
ARAB HEALTH
Supersonic Imagine

Channels

Radiography

view channel

Low-Dose CT Offers Cost-Effective Lung Screening

A new statistical analysis of from a US lung screening trial concluded that performing low-dose computed tomography (CT) screening can be cost-effective compared to doing no screening for lung cancer in aging smokers. “This provides evidence, given the assumptions we used, that it is cost-effective,” said Ilana Gareen,... Read more

Nuclear medicine

view channel
Image: The MRIdian MRI-guided radiation therapy system (Photo courtesy of ViewRay).

World’s First Clinical MRI-Guided Radiation Therapy System Awarded CE Marking

The world’s first magnetic resonance imaging (MRI)-guided radiation therapy system has received CE marking approval, which will allow the developer of the technology to deliver the systems throughout Europe... Read more

General/Advanced Imaging

view channel

Photoacoustic Imaging Optimizes Visualization of Cancerous Tissues Using Time Reversal Technology

Unique time-reversal technology is being used to better focus light in tissue, such as muscles and organs. Current high-resolution optical imaging technology allows researchers to see about 1-mm-deep into the body. In an effort to enhance this imaging technology, the investigators are employing photoacoustic imaging, which... Read more

Imaging IT

view channel

Imaging Data, Tools Developed for Heart Disease Research

A virtual machine is being developed to optimize reproducibility and data availability to assess and enhance analyses of magnetic resonance imaging (MRI) myocardial perfusion data. The project was described November 11, 2014, in the open access, open data journal GigaScience. The study’s researchers, from the Universidad... Read more

Industry News

view channel
Image: Blackford Analysis accelerates image comparison (Photo courtesy of Blackford Analysis).

Partnership to Integrate Image Workflow Server into Image Viewer

Intelerad Medical Systems (Montreal, Canada), a developer of medical imaging picture archiving and communication systems (PACS), radiology information systems (RIS), and workflow solutions, reported that... Read more
 

Events

01 Dec 2014 - 05 Dec 2014
11 Jan 2015 - 14 Jan 2015
Copyright © 2000-2014 Globetech Media. All rights reserved.